Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis-Reference-Cited by-同舟云学术

Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis

Published:2015-03-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Patel Sanjay¹,Sinha Ian P¹,Dwan Kerry²,Echevarria Carlos³,Schechter Michael⁴,Southern Kevin W¹

Affiliation:

1. University of Liverpool; Department of Women's and Children's Health; Alder Hey Children's NHS Foundation Trust Eaton Road Liverpool Merseyside UK L12 2AP

2. University of Liverpool; Department of Biostatistics; Alder Hey Children's NHS Foundation Trust Eaton Road Liverpool England UK L12 2AP

3. Institute of Cellular Medicine, Newcastle University; 4th Floor, William Leech Building Framlington Place Newcastle UK NE2 4HH

4. Virginia Commonwealth University; Division of Pulmonary Medicine; Richmond Virginia USA 23298-0315

Publisher

Wiley

Subject

Pharmacology (medical)

Reference123 articles.

1. Improvement in sweat chloride concentration by the CFTR potentiator VX-770 in subjects with cystic fibrosis and the G551D-CFTR mutation [abstract;Accurso;Pediatric Pulmonology,2009

2. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation;Accurso;New England Journal of Medicine,2010

3. Online supplementary appendix to "Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation" [online];Accurso;New England Journal of Medicine,2010

4. Online supplementary material (disclosure forms) to "Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation" [online];Accurso;New England Journal of Medicine,2010

5. Online supplementary material (protocol) to "Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation" [online];Accurso;New England Journal of Medicine,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?;Pediatric Pulmonology;2023-06-06

2. A shifting landscape: Practice patterns and outcomes of cystic fibrosis and non‐cystic fibrosis pediatric lung transplantation;Pediatric Transplantation;2021-07-18

3. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes;Journal of Diabetes and its Complications;2021-06

4. The effectiveness and value of novel treatments for cystic fibrosis;Journal of Managed Care & Specialty Pharmacy;2021-02

5. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist;American Journal of Rhinology & Allergy;2020-03-13